Ahammune Biosciences: Funding, Investors & Team (Sep 2026)
Ahammune Biosciences is a drug discovery company founded in 2016 that prioritizes innovation and specializes in creating new therapies for skin conditions caused by immune system dysfunction. Our primary focus at the moment is on Vitiligo, a depigmenting disorder.
Ahammune Biosciences has raised $5.0M across 1 funding round on record, the most recent a Series A of $5.0M announced in Sep 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ahammune Biosciences Company Profile and Key Stats
Latest funding round on record: Sep 2024.
Ahammune Biosciences Funding Rounds
Ahammune Biosciences Founders and Leadership Team
Contact details for the Ahammune Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Ahammune Biosciences Funding Compared to Other Biotechnology Startups
Ahammune Biosciences' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ahammune Biosciences in Biotechnology and Pune
Companies Similar to Ahammune Biosciences
4baseCare offers advanced genomic solutions in precision oncology to assist individuals with cancer. The…
Biodimension is offering biofabricated human tissues as an efficient animal alternative testing solutions to…
Pandorum Technologies Pvt. Ltd. is a Bangalore based biotechnology company with focus on tissue engineering…
PlasmaGen BioSciences is an Indian Bio-pharmaceutical organization specializing exclusively in Plasma Protein…
Cellarim is at the forefront of the biomanufacturing revolution. As a pioneer in the biotechnology business,…
ImmunitoAI is a life sciences (biotech) platform that leverages AI to revolutionize antibody discovery &…
Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell…
QRL Bioscience is a science and technology-focused company dedicated to finding solutions for diabetic foot…
Ivory improves the aging process by promoting sharper thinking and better living. They assist in the early…
Prantae Solutions is a biotechnology company that develops cost-effective technologies for uncommon and…
ErlySign creates home-based early detection test kits for life-threatening illnesses such as Oral cancer,…
BrainSightAI is a software platform that uses MRI technology to improve accuracy in neurological and…
Ahammune Biosciences Funding FAQs
What does Ahammune Biosciences do?
Ahammune Biosciences is a drug discovery company founded in 2016 that prioritizes innovation and specializes in creating new therapies for skin conditions caused by immune system dysfunction. Our primary focus at the moment is on Vitiligo, a depigmenting disorder.
How much funding has Ahammune Biosciences raised?
Ahammune Biosciences has raised $5.0M across 1 round on record. The most recent is a Series A of $5.0M announced in Sep 2024.
When did Ahammune Biosciences last raise funding?
Ahammune Biosciences' most recent funding round on record is a Series A of $5.0M, announced in Sep 2024.
Who founded Ahammune Biosciences?
FundedIQ lists Parul Ganju (Founder) at Ahammune Biosciences.
Where is Ahammune Biosciences headquartered?
Ahammune Biosciences is based in Pune, Maharashtra, India.
How many employees does Ahammune Biosciences have?
Ahammune Biosciences is in the 1-10 employee band.
How does Ahammune Biosciences' funding compare to other Biotechnology startups?
Ahammune Biosciences' latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Ahammune Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ahammune Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.